A neurologist's personal battle against Alzheimer's disease
Two days ago, Halloween arrived at our house. It has been one of my favorite holidays since my own childhood, but now perhaps even more so, as we share in the excitement and joy...
Recently, I received an invitation to screen the documentary film A Tattoo On My Brain at my high school alma mater, Polytechnic School in Pasadena, California. Poly has it roots in what was initially Throop University,...
So far, three anti-amyloid monoclonal antibodies have been approved in the US by the FDA for treatment of dementia or mild cognitive impairment (MCI) caused by Alzheimer’s disease: aducanumab, lecanemab, and most recently donanemab....
Every summer for the last 25 years, one or two of my friends and I charter a sailboat for four to six days to sail around the San Juan and Gulf Islands that straddle...
I must admit that when I think of olive oil, I am often reminded first of Popeye’s girlfriend. No, I wasn’t around in 1936, but Olive Oyl and Popeye were still going strong when I...
A couple of days ago, Lois and I met up with old college friends who were passing through Portland. We hadn’t seen Linda and Ron for years, so there were lots of things to...
Last week I was walking with our dog Jack along the western shore of Siletz Bay on the Oregon coast. It was 7:02 pm, and the sun was low in the western sky. Looking...
The last ten days have been busy, but in a good way. As I described in the last post, Lois and I were interviewed on live radio at the Oregon Public Broadcasting (OPB) radio station...
One week ago, Lois and I were interviewed live on Think Out Loud, a daily interview show on our local public radio station, OPB (Oregon Public Broadcasting). A recording of the interview can be...
Yesterday an independent panel of experts unanimously recommended FDA approval of the anti-amyloid monoclonal antibody donanemab. I think it is very likely that full FDA approval will be forthcoming. Donanemab appears to be at least...
Recent Comments